In 2024, the U.S. Drug Enforcement Administration (DEA) indicated they plan to reclassify marijuana as being a Program III drug. This rescheduling will understand that cannabis has genuine clinical applications and will help open the doorway to analysis on other opportunity therapy works by using. Tell us about this example https://thcdisposables.co.uk/